NDRG1 and cancer: Data from the TCGA Pan‐Cancer Atlas study, covering 22179 patients and 22802 samples across 36 cancer types, showed that NDRG1 frequently undergoes mutations, amplifications, and deep deletions in various cancers, including LUAD (Figure 1F).